X4 Pharmaceuticals (XFOR) P/E (2018 - 2026)
X4 Pharmaceuticals (XFOR) P/E from Jan 2, 2018 to Jul 21, 2026. The TTM X4 Pharmaceuticals (XFOR) P/E is -0.75. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of X4 Pharmaceuticals (XFOR)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.75 | -12.70% |
| 2025 | -0.86 | -21.48% |
| 2024 | -1.10 | -25.57% |
| 2023 | -1.48 | -15.56% |
| 2022 | -1.75 | -55.56% |
| 2021 | -3.94 | -60.92% |
| 2020 | -10.07 | -24.78% |
| 2019 | -13.39 | +43.33% |
| 2018 | -9.34 | N/A |
Comparison X4 Pharmaceuticals (XFOR) P/E with competitors
X4 Pharmaceuticals (XFOR) P/E is -0.75.